These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 18089340

  • 1. Acute effects of a single dose of phosphodiesterase type 5 inhibitor (sildenafil) on systemic arterial blood pressure during exercise and 24-hour ambulatory blood pressure monitoring in heart transplant recipients.
    Guimaraes GV, d'Avila VM, Pires P, Bacal F, Stolf N, Bocchi E.
    Transplant Proc; 2007 Dec; 39(10):3142-9. PubMed ID: 18089340
    [Abstract] [Full Text] [Related]

  • 2. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
    Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ.
    Circulation; 2007 Jan 02; 115(1):59-66. PubMed ID: 17179022
    [Abstract] [Full Text] [Related]

  • 3. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
    Mahmud A, Hennessy M, Feely J.
    J Hum Hypertens; 2001 Oct 02; 15(10):707-13. PubMed ID: 11607801
    [Abstract] [Full Text] [Related]

  • 4. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
    Attinà TM, Malatino LS, Maxwell SR, Padfield PL, Webb DJ.
    J Hypertens; 2008 Mar 02; 26(3):501-7. PubMed ID: 18300861
    [Abstract] [Full Text] [Related]

  • 5. Effects of sildenafil on cardiopulmonary responses during stress.
    Stanopoulos I, Hatzichristou D, Tryfon S, Tzortzis V, Apostolidis A, Argyropoulou P.
    J Urol; 2003 Apr 02; 169(4):1417-21. PubMed ID: 12629375
    [Abstract] [Full Text] [Related]

  • 6. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ.
    Circulation; 2007 Oct 02; 116(14):1555-62. PubMed ID: 17785618
    [Abstract] [Full Text] [Related]

  • 7. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P, Parry G, Dark JH, Macgowan GA.
    J Heart Lung Transplant; 2009 Jul 02; 28(7):676-82. PubMed ID: 19560695
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR, Lee M, Tunin RS, Mahmud M, Champion HC, Kass DA.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1079-88. PubMed ID: 17349888
    [Abstract] [Full Text] [Related]

  • 12. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N, Sharma MK, Sinha N.
    Int J Cardiol; 2007 Sep 03; 120(3):306-13. PubMed ID: 17174417
    [Abstract] [Full Text] [Related]

  • 13. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ, Freestone S, Allen MJ, Muirhead GJ.
    Am J Cardiol; 1999 Mar 04; 83(5A):21C-28C. PubMed ID: 10078539
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of sildenafil on flow mediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients.
    Stirban A, Laude D, Elghozi JL, Sander D, Agelink MW, Hilz MJ, Ziegler D.
    Diabetes Metab Res Rev; 2009 Feb 04; 25(2):136-43. PubMed ID: 19116943
    [Abstract] [Full Text] [Related]

  • 15. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD, Bart BA, Webb DJ, Koren MJ, Siegel RL, Wang H, Malhotra B, Jen F, Glue P.
    Crit Care Med; 2007 Aug 04; 35(8):1863-8. PubMed ID: 17522570
    [Abstract] [Full Text] [Related]

  • 16. [The effects of enalapril on basal arterial pressure at rest and during exercise and on cardiac performance in hypertensive athletes].
    D'Este D, Giada F, Sartori F, Noventa D, Cinquemani S, Mantovan R, Pascotto P.
    G Ital Cardiol; 1990 Oct 04; 20(10):935-9. PubMed ID: 2090533
    [Abstract] [Full Text] [Related]

  • 17. Long-term use of sildenafil in the therapeutic management of heart failure.
    Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD.
    J Am Coll Cardiol; 2007 Nov 27; 50(22):2136-44. PubMed ID: 18036451
    [Abstract] [Full Text] [Related]

  • 18. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.
    Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD.
    J Am Coll Cardiol; 2004 Dec 21; 44(12):2339-48. PubMed ID: 15607396
    [Abstract] [Full Text] [Related]

  • 19. Effect of exercise training on 24-hour ambulatory blood pressure monitoring in heart failure patients.
    Carvalho VO, Ciolac EG, Guimarães GV, Bocchi EA.
    Congest Heart Fail; 2009 Dec 21; 15(4):176-80. PubMed ID: 19627291
    [Abstract] [Full Text] [Related]

  • 20. Response to exercise and ambulatory blood pressure monitoring in essential hypertension.
    Khanna CM, Dubey YS, Khanna G, Kaur G.
    J Assoc Physicians India; 1999 Apr 21; 47(4):393-6. PubMed ID: 10778522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.